BRIGHT-4 trial: bivalirudin strikes back – Authors' reply

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Access to Document

@article{53f1d7840d2d475c8c2206121fdc0c18,

title = "BRIGHT-4 trial: bivalirudin strikes back – Authors' reply",

author = "Yi Li and Zhenyang Liang and Stone, \{Gregg W.\} and Yaling Han",

year = "2023",

month = apr,

day = "8",

doi = "10.1016/S0140-6736(23)00270-2",

language = "English",

volume = "401",

pages = "1158",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "10383",

}

TY - JOUR

T1 - BRIGHT-4 trial

T2 - bivalirudin strikes back – Authors' reply

AU - Li, Yi

AU - Liang, Zhenyang

AU - Stone, Gregg W.

AU - Han, Yaling

PY - 2023/4/8

Y1 - 2023/4/8

UR - https://www.scopus.com/pages/publications/85151500298

U2 - 10.1016/S0140-6736(23)00270-2

DO - 10.1016/S0140-6736(23)00270-2

M3 - Letter

C2 - 37030890

AN - SCOPUS:85151500298

SN - 0140-6736

VL - 401

SP - 1158

JO - The Lancet

JF - The Lancet

IS - 10383

ER -